Kim Kelderman Power - 03 Nov 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
03 Nov 2025
Net transactions value
-$144,099
Form type
4
Filing time
05 Nov 2025, 16:46:58 UTC
Previous filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelderman Kim Chief Executive Officer, Director 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed. 05 Nov 2025 0001739054

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Tax liability $144,099 -2,303 -4.5% $62.57 48,665 03 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Stock Option (Right to Buy) 109,536 03 Nov 2025 Common Stock 109,536 $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 115,724 03 Nov 2025 Common Stock 115,724 $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 25,944 03 Nov 2025 Common Stock 25,944 $120.46 Direct F1
holding TECH Stock Options (Right to Buy) 28,940 03 Nov 2025 Common Stock 28,940 $94.52 Direct F1
holding TECH Performance Restricted Stock Units 8,873 03 Nov 2025 Common Stock 8,873 Direct F2, F3
holding TECH Performance Stock Options (Right to Buy) 23,881 03 Nov 2025 Common Stock 23,881 $84.61 Direct F3
holding TECH Stock Options (Right to Buy) 29,391 03 Nov 2025 Common Stock 29,391 $84.61 Direct F4
holding TECH Stock Options (Right to Buy) 38,252 03 Nov 2025 Common Stock 38,252 $52.83 Direct F5
holding TECH Performance Restricted Stock Units 9,423 03 Nov 2025 Common Stock 9,423 Direct F2, F3
holding TECH Performance Stock Options (Right to Buy) 25,945 03 Nov 2025 Common Stock 25,945 $68.54 Direct F3
holding TECH Stock Options (Right to Buy) 51,890 03 Nov 2025 Common Stock 51,890 $68.54 Direct F6
holding TECH Performance Restricted Stock Units 51,261 03 Nov 2025 Common Stock 51,261 Direct F2, F7
holding TECH Restricted Stock Units 17,087 03 Nov 2025 Common Stock 17,087 Direct F2, F8
holding TECH Stock Options (Right to Buy) 69,061 03 Nov 2025 Common Stock 69,061 $74.91 Direct F9
holding TECH Performance Restricted Stock Units 70,708 03 Nov 2025 Common Stock 70,708 Direct F2, F10
holding TECH Restricted Stock Units 35,354 03 Nov 2025 Common Stock 35,354 Direct F2, F11
holding TECH Stock Options (Right to Buy) 90,441 03 Nov 2025 Common Stock 90,441 $53.60 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F4 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
F5 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
F6 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
F7 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
F9 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
F12 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.